Accolade Pharma USA
Accolade Pharma USA

Accolade Pharma USA Information

Contact top employees from Accolade Pharma USA

Summary

Accolade Pharma USA is a privately held company. The company currently specializes in the Health, Wellness and Fitness area. Its headquarters is located at US. The estimated number of employees - 4. To connect with Accolade Pharma USA employee register on SignalHire.

Phone Number

626-279-9699

Industries

Headquarters Location

13260 E Temple Ave, City of Industry, California, 91746 US

Employees Size

10-50 employees

Specialties

Encapsulation, Tablet Press, Bottling, Blistering, Blending, Sachet Packaging, Vitamin and Supplement Manufacturing, Label Design, Packaging Design, Contract Manufacturing, Global Fulfillment & Logistic Services, Private Label Nutritional Products, Nutraceutical Testing & Analysis

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Accolade Pharma USA shows a diverse range of experience levels:
14% for 1–2 years29% for 3–4 years29% for 5–7 years14% for 8–10 years14% have over 11 years of service at Accolade Pharma USA
Contact top employees from Accolade Pharma USA
Manuel Gonzalez
Production & Packaging Coordinator
View
Taeyoung Shim
QA/QC Chemist
View
Trina Phan
Quality Assurance Quality Control Manager
View
Valerie Le
Project Manager
View
Yan Li
Chief Executive OfficerChief
View

FAQ

The headquarters of Accolade Pharma USA are located in City of Industry, United States.
You can contact Accolade Pharma USA by phone at 626-279-9699.
Accolade Pharma USA currently employs 10-50 people.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP